These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 25062880)
21. Low intratumoral regulatory T cells and high peritumoral CD8(+) T cells relate to long-term survival in patients with pancreatic ductal adenocarcinoma after pancreatectomy. Liu L; Zhao G; Wu W; Rong Y; Jin D; Wang D; Lou W; Qin X Cancer Immunol Immunother; 2016 Jan; 65(1):73-82. PubMed ID: 26646849 [TBL] [Abstract][Full Text] [Related]
22. The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patients. Cheng H; Luo G; Lu Y; Jin K; Guo M; Xu J; Long J; Liu L; Yu X; Liu C Pancreatology; 2016; 16(6):1080-1084. PubMed ID: 27665172 [TBL] [Abstract][Full Text] [Related]
23. Biological variability of lymphocyte subsets of human adults' blood. Tosato F; Bernardi D; Sanzari MC; Pantano G; Plebani M Clin Chim Acta; 2013 Sep; 424():159-63. PubMed ID: 23770423 [TBL] [Abstract][Full Text] [Related]
24. Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis. Hudnall SD; Patel J; Schwab H; Martinez J Cytometry B Clin Cytom; 2003 Sep; 55(1):22-8. PubMed ID: 12949956 [TBL] [Abstract][Full Text] [Related]
25. Analysis of some peripheral blood lymphocyte subsets in relation to Borrelia burgdorferi antibodies in patients with Lyme disease. Zajkowska JM; Hermanowska-Szpakowicz T; Wysocka J; Kondrusik M; Pancewicz SA; Grygorczuk S Rocz Akad Med Bialymst; 2000; 45():184-98. PubMed ID: 11712430 [TBL] [Abstract][Full Text] [Related]
26. The Systemic-immune-inflammation Index Independently Predicts Survival and Recurrence in Resectable Pancreatic Cancer and its Prognostic Value Depends on Bilirubin Levels: A Retrospective Multicenter Cohort Study. Aziz MH; Sideras K; Aziz NA; Mauff K; Haen R; Roos D; Saida L; Suker M; van der Harst E; Mieog JS; Bonsing BA; Klaver Y; Koerkamp BG; van Eijck CH Ann Surg; 2019 Jul; 270(1):139-146. PubMed ID: 29334554 [TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of mast cell count following curative resection for pancreatic ductal adenocarcinoma. Cai SW; Yang SZ; Gao J; Pan K; Chen JY; Wang YL; Wei LX; Dong JH Surgery; 2011 Apr; 149(4):576-84. PubMed ID: 21167541 [TBL] [Abstract][Full Text] [Related]
28. Effect of bariatric surgery on peripheral blood lymphocyte subsets in women. Merhi ZO; Durkin HG; Feldman J; Macura J; Rodriguez C; Minkoff H Surg Obes Relat Dis; 2009; 5(2):165-71. PubMed ID: 18996763 [TBL] [Abstract][Full Text] [Related]
29. Accumulation of FOXP3+T-cells in the tumor microenvironment is associated with an epithelial-mesenchymal-transition-type tumor budding phenotype and is an independent prognostic factor in surgically resected pancreatic ductal adenocarcinoma. Wartenberg M; Zlobec I; Perren A; Koelzer VH; Gloor B; Lugli A; Karamitopoulou E Oncotarget; 2015 Feb; 6(6):4190-201. PubMed ID: 25669968 [TBL] [Abstract][Full Text] [Related]
30. [Changes of lymphocyte subsets before and after chemotherapy in colorectal carcinoma patients]. Zhang GQ; Zhao H; Wen XY; Li JY; Wu LL; Jiao SC Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Apr; 35(2):155-60. PubMed ID: 23643003 [TBL] [Abstract][Full Text] [Related]
31. Intratumoral CD38 Zhu H; Xu J; Wang W; Zhang B; Liu J; Liang C; Hua J; Meng Q; Yu X; Shi S EBioMedicine; 2024 May; 103():105098. PubMed ID: 38608514 [TBL] [Abstract][Full Text] [Related]
32. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer. Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568 [TBL] [Abstract][Full Text] [Related]
33. The metastasis status and tumor burden-associated CA125 level combined with the CD4/CD8 ratio predicts the prognosis of patients with advanced pancreatic cancer: A new scoring system. Yang C; Cheng H; Luo G; Lu Y; Guo M; Jin K; Wang Z; Yu X; Liu C Eur J Surg Oncol; 2017 Nov; 43(11):2112-2118. PubMed ID: 28802662 [TBL] [Abstract][Full Text] [Related]
34. Pancreatic adenocarcinoma exerts systemic effects on the peripheral blood myeloid and plasmacytoid dendritic cells: an indicator of disease severity? Tjomsland V; Sandström P; Spångeus A; Messmer D; Emilsson J; Falkmer U; Falkmer S; Magnusson KE; Borch K; Larsson M BMC Cancer; 2010 Mar; 10():87. PubMed ID: 20214814 [TBL] [Abstract][Full Text] [Related]
35. Clinicopathological correlations of nestin expression in surgically resectable pancreatic cancer including an analysis of perineural invasion. Lenz J; Karasek P; Jarkovsky J; Muckova K; Dite P; Kala Z; Veselska R; Hermanova M J Gastrointestin Liver Dis; 2011 Dec; 20(4):389-96. PubMed ID: 22187705 [TBL] [Abstract][Full Text] [Related]
36. Circulating subsets and CD4(+)CD25(+) regulatory T cell function in chronic inflammatory demyelinating polyradiculoneuropathy. Sanvito L; Makowska A; Gregson N; Nemni R; Hughes RA Autoimmunity; 2009; 42(8):667-77. PubMed ID: 19886739 [TBL] [Abstract][Full Text] [Related]
37. Lymphocyte subsets and specific T-cell immune response in thalassemia. Pattanapanyasat K; Thepthai C; Lamchiagdhase P; Lerdwana S; Tachavanich K; Thanomsuk P; Wanachiwanawin W; Fucharoen S; Darden JM Cytometry; 2000 Feb; 42(1):11-7. PubMed ID: 10679738 [TBL] [Abstract][Full Text] [Related]
38. High expression of delta-like ligand 4 predicts poor prognosis after curative resection for pancreatic cancer. Chen HT; Cai QC; Zheng JM; Man XH; Jiang H; Song B; Jin G; Zhu W; Li ZS Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S464-74. PubMed ID: 21822553 [TBL] [Abstract][Full Text] [Related]
39. Mitochondrial transcription factor a worsens the clinical course of patients with pancreatic cancer through inhibition of apoptosis of cancer cells. Yamauchi M; Nakayama Y; Minagawa N; Torigoe T; Shibao K; Yamaguchi K Pancreas; 2014 Apr; 43(3):405-10. PubMed ID: 24622070 [TBL] [Abstract][Full Text] [Related]
40. [Differential analysis of lymphocyte subsets between colorectal carcinoma patients and healthy individuals]. Zhang GQ; Jiao SC; Wen XY; Zhao H; Lin XS; Wu LL Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jul; 28(7):735-7. PubMed ID: 22768866 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]